SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Mintz Mark
(Last) (First) (Middle)
C/O CHARLES RIVER LABORATORIES
251 BALLARDVALE ST
(Street)
WILMINGTON MA 01887
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2025 		3. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. [ CRL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Information Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 6,350(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) 03/01/2022(2) 03/01/2031 Common Stock 3,219 $289.61 D
Stock Options (Right to Buy) 05/28/2022(2) 05/28/2031 Common Stock 1,098 $337.99 D
Stock Options (Right to Buy) 05/27/2023(3) 05/27/2032 Common Stock 1,437 $244.41 D
Stock Options (Right to Buy) 05/26/2024(4) 05/26/2033 Common Stock 1,730 $194.12 D
Stock Options (Right to Buy) 05/31/2025(5) 05/31/2034 Common Stock 1,635 $208.44 D
Explanation of Responses:
1. Includes (a) 133 restricted stock units (RSUs) which vest on 5/27/2026, (b) 361 restricted stock units (RSUs) which vest as follows: 180 on 5/26/2026 and 181 on 5/26/2027, (c) 540 restricted stock units (RSUs) which vest as follows: 180 on 5/31/2026, 180 on 5/31/2027 and 180 on 5/31/2028 and (d) 3,244 restricted stock units (RSUs) which vest as follows: 811 on 5/30/2026, 811 on 5/30/2027, 811 on 5/30/2028 and 811 on 5/30/2029.
2. Stock Options fully vested.
3. 1,077 Stock Options are vested, and the remaining Stock Options will vest on 5/27/2026.
4. 865 Stock Options are vested, and the remaining Stock Options will vest as follows: 432 on 5/26/2026 and 433 on 5/26/2027.
5. 408 Stock Options are vested, and the remaining Stock Options will vest as follows: 409 on 5/31/2026, 409 on 5/31/2027 and 409 on 5/31/2028.
/s/ Mark Mintz 06/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.